Aflibercept for Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in Germany: Twelve-Month Outcomes of PERSEUS

MLA

Carsten, Framme, et al. “Aflibercept for Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in Germany: Twelve-Month Outcomes of PERSEUS.” Ophthalmology. Retina, vol. 2, no. 6, May 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........79ad9731b0fc93106e1e1c752b647d88&authtype=sso&custid=ns315887.

APA

Carsten, F., Nicole, E., Thomas, H., Zoran, H., Claudia, J., Kristian T, J., Miriam, K., Helmut, S., Harald, S., Ulrich, T., Peter, W., & Joachim, W. (2017). Aflibercept for Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in Germany: Twelve-Month Outcomes of PERSEUS. Ophthalmology. Retina, 2(6).

Chicago

Carsten, Framme, Eter Nicole, Hamacher Thomas, Hasanbasic Zoran, Jochmann Claudia, Johnson Kristian T, Kahl Miriam, et al. 2017. “Aflibercept for Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in Germany: Twelve-Month Outcomes of PERSEUS.” Ophthalmology. Retina 2 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........79ad9731b0fc93106e1e1c752b647d88&authtype=sso&custid=ns315887.